Effect of Aloe on Learming and Memory lmpaiments in Dementia Animal Model SAMP8

치매동물모델 SAMP8에 있어서 기억. 학습장해에 미치는 알로에의 영향 III. SAMP8의 신경전달물질 및 그 대사산물에 미치는 알로에의 투여효과

  • 최진호 (부경대학교 식품생명과학과) ;
  • 김동우 (부경대학교 식품생명과학과) ;
  • 김재일 (부경대학교 식품생명과학과) ;
  • 한상섭 (한국화학연구소 안전성연구센터) ;
  • 심창섭 (김정문알로에기술연구소)
  • Published : 1996.06.01

Abstract

Aloe(Aloe arborescens M$_{ILL}$) has been used as a home medicine for the past several thousand in the world, and has been studied on anti-bacterial and anti-fungal activities, hypotension, atherosclerosis, myocardiac infartion, apoplexy, diabetes as a chronic digenerative disease, tumors, gastrointestinal tract, liver and pancreas' diseases, and genitourinary tract etc. SAMP8 as a learing and memory impairment animal model were fed basic and/or experimental diets with 1.0% freezing dried(FD)-aloe for 8 months. The passive avoidance tests such as acqusition trial and retention test were significantly higher in aloe group than in control group. Grading score of senescence resulted in a marked decreases in aloe group compared with control group. Acetylcholinesterase(AChE) activity was remarkably increased in aloe group compared with control group. Neurotransmitters such as dopamine(DA) and serotonin(5-HT) almost did not change by the feeding of aloe-added diet, but their metabolites such as homovanillic acid(HVA) and 5-hydroxy-indole acetic acid(5-HIAA) in aloe group were significantly increased compared with control group. Therefore, the ratios of HVA/DA and 5-HIAA/5-HT as a ratio of metabolite on neurotransmitter were significantly increased by the feeding of aloe-added diet. These results suggest that aloe vara may be activated acetylcholinesterase, the metabolite of neurotransmitter, and ratios of metabolite on neurotransmitter, resulting ina greater prevention of learning and memory impairments such as Alzheimertype dementia.

Keywords

References

  1. Arch. Intern. Pharmacodya v.120 no.2 The mechanism of the hypotensive effect of lignum aloes Benbassat J.;Sulman F. G.;Zaitschek D. V.
  2. Uchcnye Zapiski 2-ol Moscow Med. Inst. v.6 Effect of aloe extracts on the accumulation of calcium-45 and phosphoruw-32 in normal and calloused bones Shamatov N. M.
  3. Klin Khir. v.11 Results of conservestive treatment of patients with endarteriosis and atherosclerosis of vessels of the extremities in out and in patients conditions Zaitsev G. P.;Poriadin V. T.;Rozenfel'd E. S.
  4. Int. J. Dermatol. v.12 no.1 Use of aloe in treating leh ulcers and dermatoses Zawahry M. E.;Hegazy M. R.;Helal M.;Helal M.
  5. Vrach. Delo. v.0 no.8 Use of aloe in complex treatment of patients with focal fulmunary tuberculosis Kurilenko N. A.
  6. Japan Kyodai. IP 53059019 27 Anti-infla-mmatory compositions cintaining aloe eptracts and steroids Shinpo M.;Kameyama S.;Tokita F.
  7. Oftalmol. Zh. v.6 Moderate local hypothermia and its use in certain eye diseases Chanchikov G. F.;Miminoshvili Sla
  8. Kosmet. Toiletries v.95 no.11 Aloe as a humectant in new skin preparations Meadows T. P.
  9. Arch. Inst. Pasteur Madagascar v.47 no.1 Immunostimulant properties of an extract isolated and partially purified from aloe vahombe Solar S.;Zeller H.;Raxolofonirina N.;Coulanges P. etal.
  10. Belg. BE892207 A2 16 Jun Weight contro composition De Valck W.
  11. Fureguransu Janaru v.11 no.3 Pharmaceutical effect and application of aloe to medicine Suzuki Y.
  12. Pharmacist Medical control composition Fischer J. M.
  13. Acta Dermatol. Venereol v.62 no.1 Inhibition of arachidonic acid oxidation in vitro by vehicle components Penneys N. S.
  14. Cosmet. Toiletries v.98 no.6 Possible mechanisms of the healing actions of aloe gel Rubel B. L.
  15. Pct Int. Appl., Wo 9108751 A1 27 JUN The use of sibberellins for the treatment of prostatitis and psoriasis Oden P.
  16. Annu. Rev. Neurosci. v.9 New perspective on Alzheimer's disease Price D. L.
  17. J. Neuropath. Neurobiol. v.53 Alzheimer's disease : a central role for amyloid Selkoe D. J.
  18. Arch. Neurol. v.32 Cerebral blood flow in dementia Hachiski V. C.;Iliff L. D.;Zilhka et al.
  19. In Senile Dementia, Outlook for the furture Transmission of unconventional slow virus disease and the relevance to SD/SDAT transmission studies Carp R. I.;Merz G. S.;Wisniewski H. M.;J. Wertheimer;M. Marais;Alan R.;Liss
  20. The SAM Model of Senescence A method of evaluation of the degree of senescence in senescence-ac-celerated mouse(SAM) Hosokawa M.;Toshio Takeda
  21. Brain Research v.474 Agerelated deterioration of ability of aqusition in memory and learning in SAM-P/8 as an animal model of distubances in recent memory Yagi H.;Katoh S.;Akiguchi I.;Takeda T.
  22. Neuropharmacol. v.26 no.6 A comparison of the effects of two inhibitors on brain cholinesterase Hallak M.;Giacobini E.
  23. J. Chromatography v.309 Rapid automated analysis reversed-phase high performance liquid chromatography with electrochemical detection Saller C. E.;Salama A. I.
  24. Neurobiology of Aging Age changes in the human for some enzymes associated with metabolism of catecholamines, GABA, and acetylcholine MeGeer E. G.;McGeer P. L.;Ordy JM;Brizzee
  25. Neurobiol. Aging v.1 Agerelated alterations in the rodint brain cholinergic system and behavior Strong R.;Hsu L.;Bartus R. T.;Enna S. J.
  26. Age v.4 Deficiencies in the cholinergic nervous system of the rat cerebrum as a function Sastry B. V.;Janson V. E.;Jaiswal N.;Tayeb O. S.
  27. Brain Res. v.192 Evidence for selective loss of brain dopamine and fistamine-stimulated adenylate cyclase activities in rabbits wirh aging Markman M. H.;Ahn H. S.;Thal L. S.;sharpless N. S.;Dvorkin B.;Horowitz. S. G.;Rosenfeld M.
  28. The SAM Model of Senescence Senescence-accelerated mouse(SAM). A novel murine model of aging Takeda T.;Hosokawa M.;Higuchi K.;Toshio Takeda